"New Science" is Leading Growth While Changing the Market Dynamics of the Biopharma Industry, According to New Research from Accenture
NEW YORK: April 4, 2019 – The adoption of a unique combination of the best in science and health technology such as genomics, biomarkers and companion technologies are expected to be the biopharmaceutical industry’s new growth machine, according to new research from Accenture (NYSE: ACN).
from News | Accenture Newsroom https://ift.tt/2IikJx1
from News | Accenture Newsroom https://ift.tt/2IikJx1
Comments
Post a Comment